ISS\|DNA show promise as Th1\|promoting adjuvants and immunotherapeutic agents in treatment of cancers, infection, hematopoietic damage, immunosuppression, and asthma.\;

• ISS-DNA不仅有望成为新一代高效低毒的免疫佐剂,而且在抗肿瘤、抗感染、促进造血、治疗免疫缺陷以及防治哮喘等方面均有非常乐观的应用前景。